P.S. Pucci's ruminations on Phase II and III trial designs in cancer are interesting to listen to.
Yes, if you can actually understand what this idiot is ever talking about. ARQL really needs a more understandable spokesperson/CEO. I bet 50% of what he says is lost in translation at first.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.